Filing Details

Accession Number:
0001209191-14-070490
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-20 20:22:06
Reporting Period:
2014-11-18
Filing Date:
2014-11-20
Accepted Time:
2014-11-20 20:22:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1484565 Capnia Inc. CAPN Electromedical & Electrotherapeutic Apparatus (3845) 770523891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218860 J Steinar Engelsen C/O Capnia, Inc., 3 Twin Dolphin Dr,
Suite 160
Redwood City CA 94065
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-18 436 $0.00 479 No 4 C Direct
Common Stock Acquisiton 2014-11-18 260 $0.00 739 No 4 C Direct
Common Stock Acquisiton 2014-11-18 2,643 $0.00 3,382 No 4 P Direct
Common Stock Acquisiton 2014-11-18 468 $0.00 3,850 No 4 P Direct
2010/2012 Convertible Promissory Notes Disposition 2014-11-18 12,873 $0.00 0 No 4 S Direct
2014 Convertible Promissory Notes Disposition 2014-11-18 2,134 $0.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 P Direct
No 4 P Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C Preferred Stock Disposition 2014-11-18 436 $0.00 436 $0.00
Common Stock Series B Preferred Stock Disposition 2014-11-18 260 $0.00 260 $0.00
Common Stock Warrant to Purchase Common Stock Acquisiton 2014-11-18 436 $0.00 436 $4.87
Common Stock Series A Warrant to Purchase Common Stock Acquisiton 2014-11-18 468 $0.00 468 $6.50
Common Stock Series B Warrant to Purchase Common Stock Acquisiton 2014-11-18 468 $0.00 468 $6.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
436 No 4 J Direct
468 2014-11-18 2019-11-12 No 4 P Direct
936 2014-11-18 2016-02-12 No 4 P Direct
Footnotes
  1. The Series C Preferred Stock converted into shares of Common Stock on a 1:1 basis and had no expiration date.
  2. The Series B Preferred Stock converted into shares of Common Stock on a 1:1 basis and had no expiration date.
  3. The reporting person converted an aggregate of $12,873.33 in principal amount and accrued interest under the 2010/2012 Convertible Promissory Notes on November 18, 2014, at a conversion price of $4.8675 per share, resulting in an acquisition of 2,643shares of Common Stock. The 2012/2012 Convertible Promissory Notes were convertible into shares of Common Stock at a conversion price equal to 75% of the market price of the Common Stock on the date of conversion, which was $6.49 per share of Common Stock.
  4. The reporting person converted an aggregate of $2,133.95 in principal amount and accrued interest under the 2014 Convertible Promissory Notes on November 18, 2014, at a conversion price of $4.55 per Unit, resulting in an acquisition of 468 Units. The 2014 Convertible Promissory Notes were convertible into Units at a conversion price equal to 70% of the market price of the Units being sold on the date of conversion, which was $6.50 per Unit, with each Unit consisting of (i) one share of Common Stock, (ii) one Series A Warrant to purchase one share of Common Stock, and (iii) one Series B Warrant to purchase one share of Common Stock.
  5. The 2010/2012 Warrants to Purchase Common Stock were issued in connection with the 2010/2012 Convertible Promissory Notes and on November 18, 2014, became exercisable for that number of shares of Common Stock as is equal to the quotient of (x) and (y), where (x) is equal to 25% of the principal amount of the corresponding 2010/2012 Convertible Promissory Note in connection with which such warrant was issued and which is referenced in footnote 3, and, (y) is equal to 75% of the market price of the Common Stock on November 18, 2014, which was $6.49 per share of Common Stock. The exercise price for each of the warrants is $4.8675 per share which is equal to 75% of the market price of the Common Stock on November 18, 2014, which was $6.49 per share of Common Stock. The 2010/2012 Warrants to Purchase Common Stock expire on either February 10, 2020 or January 17, 2022, as more particularly set forth in each 2010/2012 Warrant to Purchase Common Stock.